AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional Study
Objective. The relationship between metabolic risk and ovarian function is ambiguous. This retrospective study analyzed the medical records of 461 PCOS patients collected between January 2019 and June 2020 to investigate the relationship between serum anti-Müllerian hormone (AMH) and parameters of m...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2021/9511772 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832555505512349696 |
|---|---|
| author | Miaoxian Ou Pei Xu Han Lin Kaichi Ma Mingxing Liu |
| author_facet | Miaoxian Ou Pei Xu Han Lin Kaichi Ma Mingxing Liu |
| author_sort | Miaoxian Ou |
| collection | DOAJ |
| description | Objective. The relationship between metabolic risk and ovarian function is ambiguous. This retrospective study analyzed the medical records of 461 PCOS patients collected between January 2019 and June 2020 to investigate the relationship between serum anti-Müllerian hormone (AMH) and parameters of metabolic risk in the population with polycystic ovary syndrome (PCOS). Methods. A total of 461 PCOS patients aged 20–40 years were included and stratified into four groups according to the AMH level. The association between AMH and the parameters related to metabolic risk in these groups was compared, and the discrepancies were further explored. Binary logistic regression was performed to examine the risk factors of HOMA-IR. The values of AMH that best predicted the risk of HOMA-IR were also analyzed by ROC curves. Results. AMH was negatively associated with HOMA-IR (odds ratio (OR) −0.279, 95% confidence interval (CI) −0.36 to −0.20), fasting insulin (OR −0.282, 95% CI −0.36 to −0.20), 1-hour postprandial insulin (OR −0.184, 95% CI −0.28 to −0.11), 2-hour postprandial insulin (−0.180, 95%CI −0.28 to −0.11), 3-hour postprandial insulin (OR −0.198, 95% CI –0.30 to −0.13), waist-hip ratio (OR −0.235, 95% CI −0.31 to −0.14), and body mass index (OR −0.350, 95% CI −0.43 to −0.27). There was no statistically significant relationship between blood pressure, serum glucose profile, or lipid levels and AMH. Binary logistic regression showed that AMH protected against the occurrence of PCOS patients (OR: 0.835, 0.776, and 0.898). For the prediction of HOMA-IR, AMH had an AUC-ROC of 0.704 (95% CI 0.652–0.755) with a cutoff value of 7.81 mmol/L, a sensitivity of 70.3%, and a specificity of 70.1%. Conclusions. Higher AMH levels were significantly associated with a lower insulin profile and might be a useful predictor for HOMA-IR in PCOS patients. |
| format | Article |
| id | doaj-art-f26011eb42d5434dbf5173a695a5dea1 |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-f26011eb42d5434dbf5173a695a5dea12025-02-03T05:48:11ZengWileyInternational Journal of Endocrinology1687-83371687-83452021-01-01202110.1155/2021/95117729511772AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional StudyMiaoxian Ou0Pei Xu1Han Lin2Kaichi Ma3Mingxing Liu4Department of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Gynecology of Traditional Chinese Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaObjective. The relationship between metabolic risk and ovarian function is ambiguous. This retrospective study analyzed the medical records of 461 PCOS patients collected between January 2019 and June 2020 to investigate the relationship between serum anti-Müllerian hormone (AMH) and parameters of metabolic risk in the population with polycystic ovary syndrome (PCOS). Methods. A total of 461 PCOS patients aged 20–40 years were included and stratified into four groups according to the AMH level. The association between AMH and the parameters related to metabolic risk in these groups was compared, and the discrepancies were further explored. Binary logistic regression was performed to examine the risk factors of HOMA-IR. The values of AMH that best predicted the risk of HOMA-IR were also analyzed by ROC curves. Results. AMH was negatively associated with HOMA-IR (odds ratio (OR) −0.279, 95% confidence interval (CI) −0.36 to −0.20), fasting insulin (OR −0.282, 95% CI −0.36 to −0.20), 1-hour postprandial insulin (OR −0.184, 95% CI −0.28 to −0.11), 2-hour postprandial insulin (−0.180, 95%CI −0.28 to −0.11), 3-hour postprandial insulin (OR −0.198, 95% CI –0.30 to −0.13), waist-hip ratio (OR −0.235, 95% CI −0.31 to −0.14), and body mass index (OR −0.350, 95% CI −0.43 to −0.27). There was no statistically significant relationship between blood pressure, serum glucose profile, or lipid levels and AMH. Binary logistic regression showed that AMH protected against the occurrence of PCOS patients (OR: 0.835, 0.776, and 0.898). For the prediction of HOMA-IR, AMH had an AUC-ROC of 0.704 (95% CI 0.652–0.755) with a cutoff value of 7.81 mmol/L, a sensitivity of 70.3%, and a specificity of 70.1%. Conclusions. Higher AMH levels were significantly associated with a lower insulin profile and might be a useful predictor for HOMA-IR in PCOS patients.http://dx.doi.org/10.1155/2021/9511772 |
| spellingShingle | Miaoxian Ou Pei Xu Han Lin Kaichi Ma Mingxing Liu AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional Study International Journal of Endocrinology |
| title | AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional Study |
| title_full | AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional Study |
| title_fullStr | AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional Study |
| title_full_unstemmed | AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional Study |
| title_short | AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional Study |
| title_sort | amh is a good predictor of metabolic risk in women with pcos a cross sectional study |
| url | http://dx.doi.org/10.1155/2021/9511772 |
| work_keys_str_mv | AT miaoxianou amhisagoodpredictorofmetabolicriskinwomenwithpcosacrosssectionalstudy AT peixu amhisagoodpredictorofmetabolicriskinwomenwithpcosacrosssectionalstudy AT hanlin amhisagoodpredictorofmetabolicriskinwomenwithpcosacrosssectionalstudy AT kaichima amhisagoodpredictorofmetabolicriskinwomenwithpcosacrosssectionalstudy AT mingxingliu amhisagoodpredictorofmetabolicriskinwomenwithpcosacrosssectionalstudy |